Outlook Therapeutics Inc (OTLK)
8.43
+0.24
(+2.93%)
USD |
NASDAQ |
Apr 26, 16:00
8.42
-0.01
(-0.12%)
After-Hours: 20:00
Outlook Therapeutics Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| September 30, 2019 | -0.4373M |
| June 30, 2019 | -1.700M |
| March 31, 2019 | -1.717M |
| December 31, 2018 | -1.942M |
| September 30, 2018 | -2.781M |
| June 30, 2018 | -1.542M |
| March 31, 2018 | -1.450M |
| December 31, 2017 | -1.219M |
| September 30, 2017 | -0.2921M |
| Date | Value |
|---|---|
| June 30, 2017 | -0.5965M |
| March 31, 2017 | -0.9728M |
| December 31, 2016 | -0.8823M |
| September 30, 2016 | -1.098M |
| June 30, 2016 | -4.064M |
| March 31, 2016 | -7.101M |
| December 31, 2015 | -8.641M |
| September 30, 2015 | -8.804M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.700M
Minimum
Jun 2019
-0.4373M
Maximum
Sep 2019
-1.069M
Average
-1.069M
Median
Cash from Investing (TTM) Benchmarks
| Cutera Inc | 165.00M |
| Actinium Pharmaceuticals Inc | -0.153M |
| GT Biopharma Inc | -2.009M |
| Karyopharm Therapeutics Inc | 7.94M |
| Marinus Pharmaceuticals Inc | -28.60M |